CD19 and B-cell non-Hodgkin lymphoma: A study of 31 patients who received CD19 CAR-T for B-cell lymphoma under clinical trial showed delayed CD4 recovery in three out of nine patients tested one year after CAR-T, and in two out of seven patients tested two years after CAR-T [9].